• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标准化可加速药物基因组学的应用:现状与未来之路

Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.

作者信息

Caudle Kelly E, Keeling Nicholas J, Klein Teri E, Whirl-Carrillo Michelle, Pratt Victoria M, Hoffman James M

机构信息

Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Department of Pharmacy Administration, University of Mississippi School of Pharmacy, Oxford, MS 38655, USA.

出版信息

Pharmacogenomics. 2018 Jul 1;19(10):847-860. doi: 10.2217/pgs-2018-0028. Epub 2018 Jun 19.

DOI:10.2217/pgs-2018-0028
PMID:29914287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6123879/
Abstract

Successfully implementing pharmacogenomics into routine clinical practice requires an efficient process to order genetic tests and report the results to clinicians and patients. Lack of standardized approaches and terminology in clinical laboratory processes, ordering of the test and reporting of test results all impede this workflow. Expert groups such as the Association for Molecular Pathology and the Clinical Pharmacogenetics Implementation Consortium have published recommendations for standardizing laboratory genetic testing, reporting and terminology. Other resources such as PharmGKB, ClinVar, ClinGen and PharmVar have established databases of nomenclature for pharmacogenetic alleles and variants. Opportunities remain to develop new standards and further disseminate existing standards which will accelerate the implementation of pharmacogenomics.

摘要

要成功将药物基因组学应用于常规临床实践,需要一个有效的流程来安排基因检测,并将结果报告给临床医生和患者。临床实验室流程、检测安排以及检测结果报告中缺乏标准化方法和术语,都阻碍了这一工作流程。分子病理学协会和临床药物基因组学实施联盟等专家小组已发布了关于规范实验室基因检测、报告和术语的建议。其他资源,如药物基因组学知识数据库(PharmGKB)、临床变异数据库(ClinVar)、临床基因组资源(ClinGen)和药物变异数据库(PharmVar),已经建立了药物遗传等位基因和变异的命名数据库。开发新的标准并进一步推广现有标准仍有机会,这将加速药物基因组学的实施。

相似文献

1
Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.标准化可加速药物基因组学的应用:现状与未来之路
Pharmacogenomics. 2018 Jul 1;19(10):847-860. doi: 10.2217/pgs-2018-0028. Epub 2018 Jun 19.
2
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.药物遗传学等位基因命名法:检测结果报告的国际工作组建议
Clin Pharmacol Ther. 2016 Feb;99(2):172-85. doi: 10.1002/cpt.280. Epub 2015 Nov 20.
3
Evidence and resources to implement pharmacogenetic knowledge for precision medicine.实施精准医学药物遗传学知识的证据和资源。
Am J Health Syst Pharm. 2016 Dec 1;73(23):1977-1985. doi: 10.2146/ajhp150977.
4
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).临床药物遗传学检测结果术语标准化:来自临床药物遗传学实施联盟(CPIC)的共识术语
Genet Med. 2017 Feb;19(2):215-223. doi: 10.1038/gim.2016.87. Epub 2016 Jul 21.
5
Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.评估CPIC指南中涉及的药物基因组学知识对中国儿科患者的临床影响。
Pharmacogenomics. 2020 Feb;21(3):209-219. doi: 10.2217/pgs-2019-0153.
6
The challenges of implementing pharmacogenomic testing in the clinic.在临床中实施药物基因组学检测的挑战。
Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):567-577. doi: 10.1080/14737167.2017.1385395. Epub 2017 Oct 3.
7
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.DPYD基因分型建议:分子病理学协会、美国医学遗传学与基因组学学会、临床药物基因组学实施联盟、美国病理学家学会、荷兰皇家药剂师协会荷兰药物基因组学工作组、欧洲药物基因组学与个性化治疗学会、药物基因组学知识库以及药物基因变异联盟的联合共识建议
J Mol Diagn. 2024 Oct;26(10):851-863. doi: 10.1016/j.jmoldx.2024.05.015. Epub 2024 Jul 18.
8
[How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].[如何基于药物遗传学信息进行个体化药物治疗?已发表指南的系统评价]
Dtsch Med Wochenschr. 2016 Oct;141(21):e183-e202. doi: 10.1055/s-0042-100973. Epub 2016 Oct 17.
9
Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).开发知识资源以支持精准医学:来自临床药物基因组学实施联盟(CPIC)的原则
J Am Med Inform Assoc. 2016 Jul;23(4):796-801. doi: 10.1093/jamia/ocw027. Epub 2016 Mar 28.
10
Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.从发现到实施,宿主遗传分析提高结直肠癌药物安全性。
Drug Resist Updat. 2018 Jul;39:18-40. doi: 10.1016/j.drup.2018.07.001. Epub 2018 Jul 10.

引用本文的文献

1
Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communities.迈向药物基因组学(PGx)综合资源:来自基因组医学领域的调查结果。
Genet Med. 2025 Jul 12;27(10):101529. doi: 10.1016/j.gim.2025.101529.
2
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing.组合精神病学检测后药物基因组学表型的重新解释
Pharmacogenomics. 2025 Jan-Feb;26(1-2):1-7. doi: 10.1080/14622416.2025.2479409. Epub 2025 Mar 20.
3
Integrating Pharmacogenomics into the Broader Construct of Genomic Medicine: Efforts by the ClinGen Pharmacogenomics Working Group (PGxWG).将药物基因组学整合到更广泛的基因组医学架构中:临床基因组资源药物基因组学工作组(PGxWG)的工作
Clin Chem. 2025 Jan 3;71(1):36-44. doi: 10.1093/clinchem/hvae181.
4
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.药物基因组学全球研究网络实施工作组:全球合作推进药物基因组学实施。
Pharmacogenet Genomics. 2025 Jan 1;35(1):1-11. doi: 10.1097/FPC.0000000000000547. Epub 2024 Oct 3.
5
Pharmacogenomics and Big Data in medical oncology: developments and challenges.肿瘤医学中的药物基因组学与大数据:进展与挑战
Ther Adv Med Oncol. 2024 Oct 18;16:17588359241287658. doi: 10.1177/17588359241287658. eCollection 2024.
6
Mental Health Prescribers' Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region.中东和北非地区心理健康处方医生对药物遗传学检测在抑郁症管理中的应用认知
Pharmgenomics Pers Med. 2023 May 30;16:503-518. doi: 10.2147/PGPM.S410240. eCollection 2023.
7
Development and application of a computable genotype model in the GA4GH Variation Representation Specification.GA4GH 变异表示规范中可计算基因型模型的开发与应用。
Pac Symp Biocomput. 2023;28:383-394.
8
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants.临床中的药物遗传学应用:种系变异的信息与指南
Cancer Drug Resist. 2019 Mar 19;2(1):53-68. doi: 10.20517/cdr.2018.25. eCollection 2019.
9
Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.推进单基因检测向药物基因组学预测性检测的发展。
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:449-473. doi: 10.1146/annurev-genom-111621-102737. Epub 2022 May 10.
10
Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.儿科肿瘤学医护人员及其患者对药物遗传学检测的接受程度。
J Pediatr Hematol Oncol Nurs. 2022 May-Jun;39(3):168-177. doi: 10.1177/10434542211055999.

本文引用的文献

1
Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.预先药物遗传学检测:探索美国支付方的知识和观点。
Genet Med. 2019 May;21(5):1224-1232. doi: 10.1038/gim.2017.181. Epub 2017 Oct 26.
2
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.临床 CYP2C19 基因分型等位基因选择建议:分子病理学协会的报告。
J Mol Diagn. 2018 May;20(3):269-276. doi: 10.1016/j.jmoldx.2018.01.011. Epub 2018 Feb 21.
3
Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.预先获取遗传药理学信息对临床结果的益处。
Clin Pharmacol Ther. 2018 May;103(5):787-794. doi: 10.1002/cpt.1035. Epub 2018 Mar 13.
4
Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health Record.在电子健康记录中实施整合的药物基因组学决策支持时的技术挑战与机遇
Stud Health Technol Inform. 2017;245:1255.
5
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.药物基因变异(PharmVar)联盟:纳入人类细胞色素 P450(CYP)等位基因命名数据库。
Clin Pharmacol Ther. 2018 Mar;103(3):399-401. doi: 10.1002/cpt.910. Epub 2017 Nov 14.
6
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.临床药物遗传学实施联合会指南与荷兰药物遗传学工作组指南的比较。
Clin Pharmacol Ther. 2018 Apr;103(4):599-618. doi: 10.1002/cpt.762. Epub 2017 Oct 10.
7
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.精神科商业药物遗传学检测的系统评价:聚焦CYP2D6和CYP2C19等位基因覆盖范围及结果报告
Pharmacogenet Genomics. 2017 Nov;27(11):387-393. doi: 10.1097/FPC.0000000000000303.
8
Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.医疗服务提供者教育以支持药物基因组学在实践中的整合:eMERGE 网络的经验。
Pharmacogenomics. 2017 Jul;18(10):1013-1025. doi: 10.2217/pgs-2017-0038. Epub 2017 Jun 22.
9
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.基于药物基因组学的即时临床决策支持显著改变药物处方。
Clin Pharmacol Ther. 2017 Nov;102(5):859-869. doi: 10.1002/cpt.709. Epub 2017 Jun 15.
10
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.将药物基因组学检测引入临床实践中的经验教训。
Value Health. 2017 Jan;20(1):54-59. doi: 10.1016/j.jval.2016.08.727. Epub 2016 Oct 21.